COVID-19 Vaccines in Florida

The U.S. Food and Drug Administration authorized emergency use of the Moderna and Pfizer-BioNTech COVID-19 vaccine for the prevention of COVID-19 to include use in children down to six months of age. Enrolled providers are able to order COVID-19 vaccines for this age group through Florida SHOTS. Learn more.

The U.S. Food and Drug Administration (FDA) revised the Emergency Use Authorization (EUA) to discontinue the administration of sotrovimab. Bebtelovimab is Florida’s only available monoclonal antibody treatment.

Guidance for Pediatric COVID-19 Vaccines
Based on currently available data, healthy children aged 5 to 17 may not benefit from receiving the currently available COVID-19 vaccine. The Department recommends that children with underlying conditions are the best candidates for the COVID-19 vaccine.

The U.S. Food and Drug Administration (FDA) revised the Emergency Use Authorizations (EUA) for Eli Lilly’s bamlanivimab-etesevimab and Regeneron’s REGEN-COV monoclonal antibody treatments, discontinuing their use by any U.S. state or jurisdiction. The full Florida Department of Health press release can be found here.

The CDC recommends that moderately or severely immunocompromised children 5-11 years old receive an additional primary dose of vaccine 28 days after their second shot. At this time, only the Pfizer-BioNTech vaccine is authorized and recommended for this use.

The CDC recommends that people can now receive a booster shot five months after completing their Pfizer-BioNTech primary series. The booster interval for people who received the Johnson & Johnson vaccine (two months) or the Moderna vaccine (six months), is unchanged.